Table 2.
Clinical parameters, urinary podocyte markers, and areas of dense deposition in patients with lupus nephritis
| Patient | Sex | Age, yr | Class | eGFR, ml/min per 1.73 m2 |
Systolic BP, mm Hg |
Diastolic BP, mm Hg |
Total Protein, g/dl |
Albumin, g/dl |
Urinary Protein-Creatinine Ratio, g/gCre | log PodCR | log PCX | Subendothelial Dense Deposition | Subepithelial Dense Deposition |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | F | 37 | III | 85.8 | 110 | 54 | 5.7 | 3.0 | 1.46 | 2.22 | 4.66 | 1+ | — |
| 2 | F | 30 | III | 56.5 | 109 | 73 | 5.1 | 2.6 | 2.21 | 1.57 | 6.42 | 2+ | +/− |
| 3 | F | 35 | III | 42.7 | 108 | 76 | 7.0 | 3.8 | 1.31 | 3.58 | 2.87 | 1+ | — |
| 4 | F | 66 | III | 75.3 | 138 | 77 | 6.2 | 2.2 | 0.80 | N/A | 5.35 | 2+ | +/− |
| 5 | F | 16 | IV | 87.3 | 114 | 77 | 5.2 | 2.5 | 3.42 | 7.39 | 6.65 | 2+ | 1+ |
| 6 | F | 41 | IV | 37.4 | 119 | 74 | 7.8 | 1.7 | 4.43 | 8.18 | 6.28 | 3+ | 2+ |
| 7 | M | 27 | IV | 88.9 | 139 | 95 | 5.5 | 2.9 | 2.44 | 8.11 | 6.32 | 2+ | 1+ |
| 8 | F | 39 | V | 102.4 | 135 | 81 | 5.8 | 3.1 | 2.37 | 4.69 | 5.80 | — | 3+ |
| 9 | F | 44 | V | 108.0 | 92 | 68 | 6.2 | 2.9 | 0.79 | 4.92 | 5.68 | — | 3+ |
| 10 | F | 66 | V | 57.3 | 129 | 89 | 5.2 | 2.2 | 3.10 | 4.82 | 6.19 | — | 3+ |
log PodCR, log u-sed pod mRNA; log PCX, log u-sup PCX protein; F, female; 1+, weak; —, no data; 2+, intermediate; +/−, partially weak; N/A, not applicable; 3+, strong; M, male.